Tumor Mutation, T-Cell Activity, Bowel Biology, and Circulating Molecules May Predict Treatment Response

Tumor Mutation, T-Cell Activity, Bowel Biology, and Circulating Molecules May Predict Treatment Response

AnnualMeeting-SITC2017

3 years
370 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Stephen M. Ansell, MD, PhD of Mayo Clinic discusses the abstracts and new data that were presented at the second oral session for ASCO-SITC. The research focused on mutations in tumor and how those affects patients' responses to treatment. This was recorded ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Up Next Autoplay